Showing results (31-40 of 201) with videos related to
Sort By:
Pageof 21
British Journal of Haematology|January 3, 2013
BCR-ABL1 transcript at 3 months predicts long-term outcomes following second generation tyrosine kinase inhibitor therapy in the patients with chronic myeloid leukaemia in chronic phase who failed ImatinibDennis D Kim, Honggi Lee, Suzanne Kamel-Reid, et al.American Journal of Hematology|October 3, 2006
Absence of FTL3 mutations in patients with JAK2V617F mutation negative essential thrombocythemiaBruno C Medeiros, Tong Zhang, Jeffrey H Lipton, et al.Cytokines, Cellular & Molecular Therapy|December 9, 2003
Increased IFN-gamma synthesis by T cells from patients on imatinib therapy for chronic myeloid leukemiaJorg M Aswald, Jeffrey H Lipton, Sandra Aswald, et al.Acta Haematologica|May 14, 2015
Lymphoproliferative Disorders in Patients with Chronic Myeloid Leukemia: A Single-Center Case SeriesNawal F Alshehry, Mohammed Al-Huneini, Jeffrey H Lipton, et al.Journal of Translational Medicine|January 27, 2007
Therapeutic use of Aldara in chronic myeloid leukemiaAnnette M Marleau, Jeffrey H Lipton, Neil H Riordan, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 18, 2019
CNS demyelination after initiating the tyrosine kinase inhibitor imatinib: A report of two casesDalia L Rotstein, Katherine Sawicka, Aditya Bharatha, et al.European Journal of Haematology|October 31, 2020
Comorbidity profile of adult survivors at 20 years following allogeneic hematopoietic cell transplantationAyesh K Seneviratne, Clare Wright, Wilson Lam, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2008
Favorable overall survival with fully myeloablative allogeneic stem cell transplantation for follicular lymphomaJohn Kuruvilla, Gregory Pond, Richard Tsang, et al.Annals of Hematology|July 18, 2024
Practical considerations in the management of patients treated with bosutinib for chronic myeloid leukemiaJeffrey H Lipton, Tim H Brümmendorf, Kendra Sweet, et al.Clinical Lymphoma, Myeloma & Leukemia|January 26, 2024
A Review of the Therapeutic Role of Bosutinib in Chronic Myeloid LeukemiaHagop M Kantarjian, Elias J Jabbour, Jeffrey H Lipton, et al.Pageof 21